Jim Simons acquired 1.46 Million AbCellera Biologics shares worth $5.71 Million. That's 0.01% of their equity portfolio (1215th largest holding). The first AbCellera Biologics trade was made in Q2 2021. Since then Jim Simons bought shares four more times and sold shares on six occasions. The investor's estimated purchase price is $16.2 Million, resulting in a loss of 65%.